EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSMMDG00005008125
Gene Symbol: GRIK5
1 Cross references
229 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSMMDG00005005385
Gene Symbol: GRM2
1 Cross references
206 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSMMDG00005016739
Gene Symbol: GRM4
1 Cross references
196 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSMMDG00005001100
Gene Symbol: GRM4
1 Cross references
207 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSMMDG00005010304
Gene Symbol: LOC115368650
3 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSMMDG00005015799
Gene Symbol: GRIA1B
1 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3a

Ensembl ID : ENSMMDG00005024430
Gene Symbol: GRIA3A
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSMMDG00005016022
Gene Symbol: GRIA4B
1 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSMMDG00005024887
Gene Symbol: GRIN2BB
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSMMDG00005005421
Gene Symbol: GRM5A
1 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSMMDG00005021264
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase

Ensembl ID : ENSMMDG00005020570
Gene Symbol: GLS
3 Cross references
230 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).